Since EBV-encoded RNA in situ hybridization positivity is a diagnostic criteria of NKTCL [34], we hypothesized that responders could have large numbers of baseline EBV-targeting B clones directed against the underlying EBV infection and would have a less diverse BCR repertoire. This evidence concerns the gene BCR and extranodal nasal NK/T cell lymphoma.